Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Martinez, N; Almaraz, C; Vaque, JP; Varela, I; Derdak, S; Beltran, S; Mollejo, M; Campos-Martin, Y; Agueda, L; Rinaldi, A; Kwee, I; Gut, M; Blanc, J; Oscier, D; Strefford, JC; Martinez-Lopez, J; Salar, A; Sole, F; Rodriguez-Peralto, JL; Diez-Tascon, C; Garcia, JF; Fraga, M; Sebastian, E; Alves, J; Menarguez, J; Gonzalez-Carrero, J; Casado, LF; Bayes, M; Bertoni, F; Gut, I; Piris, MA.

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

LEUKEMIA. 2014; 28(6): 1334-1340 Nº de citas: 88 [doi:10.1038/leu.2013.365]

Dietrich, S; Boumendil, A; Finel, H; Avivi, I; Volin, L; Cornelissen, J; Jarosinska, RJ; Schmid, C; Finke, J; Stevens, WBC; Schouten, HC; Kaufmann, M; Sebban, C; Trneny, M; Kobbe, G; Fornecker, LM; Schetelig, J; Kanfer, E; Heinicke, T; Pfreundschuh, M; Diez-Martin, JL; Bordessoule, D; Robinson, S; Dreger, P.

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

ANNALS OF ONCOLOGY. 2014; 25(5): 1053-1058 Nº de citas: 54 [doi:10.1093/annonc/mdu097]

Xhaard, A; Rzepecki, P; Valcarcel, D; Santarone, S; Furst, S; Serrano, D; De Angelis, G; Kruger, W; Scheid, C.

Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients

BONE MARROW TRANSPLANTATION. 2014; 49(4): 509-512 Nº de citas: 1 [doi:10.1038/bmt.2013.220]

Menezes, J; Acquadro, F; Wiseman, M; Gomez-Lopez, G; Salgado, RN; Talavera-Casanas, JG; Buno, I; Cervera, JV; Montes-Moreno, S; Hernaandez-Rivas, JM; Ayala, R; Calasanz, MJ; Larrayoz, MJ; Brichs, LF; Gonzalez-Vicent, M; Pisano, DG; Piris, MA; Alvarez, S; Cigudosa, JC.

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

LEUKEMIA. 2014; 28(4): 823-829 Nº de citas: 141 [doi:10.1038/leu.2013.283]

Mollejo, M; Menarguez, J; Guisado-Vasco, P; Bento, L; Algara, P; Montes-Moreno, S; Rodriguez-Pinilla, MS; Cruz, MA; Casado, F; Montalban, C; Piris, MA.

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study

MODERN PATHOLOGY. 2014; 27(2): 281-293 Nº de citas: 16 [doi:10.1038/modpathol.2013.120]

Kwon, M; Martinez-Laperche, C; Balsalobre, P; Serrano, D; Anguita, J; Gayoso, J; Diez-Martin, JL; Buno, I.

Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells

BONE MARROW TRANSPLANTATION. 2014; 49(2): 212-218 Nº de citas: 16 [doi:10.1038/bmt.2013.177]

Guillaumet-Adkins, A; Richter, J; Odero, MD; Sandoval, J; Agirre, X; Catala, A; Esteller, M; Prosper, F; Calasanz, MJ; Buno, I; Kwon, M; Court, F; Siebert, R; Monk, D.

Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels

JOURNAL OF HEMATOLOGY & ONCOLOGY. 2014; 7: Nº de citas: 22 [doi:10.1186/1756-8722-7-4]

Pascual, C; Munoz, C; Huerta, AR; Rus, GP; Ortega, V; Corral, J; Diez-Martin, JL.

A new case of successful outcome of pregnancy in a carrier of homozygous type II ( L99F) antithrombin deficiency

BLOOD COAGULATION & FIBRINOLYSIS. 2014; 25(1): 74-76 Nº de citas: 9 [doi:10.1097/MBC.0b013e3283646620]

Re, A; Cattaneo, C; Skert, C; Balsalobre, P; Michieli, M; Bower, M; Ferreri, AJM; Hentrich, M; Ribera, JM; Allione, B; Schommers, P; Montoto, S; Almici, C; Ferremi, P; Mazzucato, M; Gattillo, S; Casari, S; Spina, M; Diez-Martin, JL; Tirelli, U; Rossi, G.

Stem cell mobilization in HIV seropositive patients with lymphoma

HAEMATOLOGICA. 2013; 98(11): 1762-1768 Nº de citas: 18 [doi:10.3324/haematol.2013.089052]

Guillem, V; Hernandez-Boluda, JC; Gallardo, D; Buno, I; Bosch, A; Martinez-Laperche, C; de la Camara, R; Brunet, S; Martin, C; Nieto, JB; Martinez, C; Perez, A; Montoro, J; Garcia-Noblejas, A; Solano, C.

A polymorphism in the TYMP gene is associated with the outcome of HLA-identical sibling allogeneic stem cell transplantation

AMERICAN JOURNAL OF HEMATOLOGY. 2013; 88(10): 883-889 Nº de citas: 7 [doi:10.1002/ajh.23523]

Serrano, D; Miralles, P; Balsalobre, P; Kwon, M; Rodriguez-Macias, G; Gayoso, J; Anguita, J; Buno, I; Berenguer, J; Diez-Martin, JL.

Graft-Versus-Tumor Effect After Allogeneic Stem Cell Transplantation in HIV-Positive Patients With High-Risk Hematologic Malignancies

AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013; 29(10): 1340-1345 Nº de citas: 10 [doi:10.1089/aid.2013.0001]

Sanz, J; Picardi, A; Boluda, JCH; Martin, C; Ferra, C; Nozzoli, C; Gonzalez-Vicent, M; Rambaldi, A; Valcarcel, D; Verdeguer, A; Serrano, D; de Heredia, CD; Pascual, MJ; de Paz, R; Montesinos, P; Bartolozzi, B; Algarotti, A; Sanz, MA; Arcese, W; Sanz, GF.

Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2013; 19(9): 1387-1392 Nº de citas: 20 [doi:10.1016/j.bbmt.2013.07.004]

Martin-Antonio, B; Suarez-Lledo, M; Arroyes, M; Fernandez-Aviles, F; Martinez, C; Rovira, M; Espigado, I; Gallardo, D; Bosch, A; Buno, I; Martinez-Laperche, C; Jimenez-Velasco, A; de la Camara, R; Brunet, S; Nieto, JB; Urbano-Ispizua, A.

A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT

BONE MARROW TRANSPLANTATION. 2013; 48(9): 1205-1211 Nº de citas: 8 [doi:10.1038/bmt.2013.43]

Sanchez-Espiridion, B; Martin-Moreno, AM; Montalban, C; Figueroa, V; Vega, F; Younes, A; Medeiros, LJ; Alves, FJ; Canales, M; Estevez, M; Menarguez, J; Sabin, P; Ruiz-Marcellan, MC; Lopez, A; Sanchez-Godoy, P; Burgos, F; Santonja, C; Lopez, JL; Piris, MA; Garcia, JF.

MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

BRITISH JOURNAL OF HAEMATOLOGY. 2013; 162(3): 336-347 Nº de citas: 34 [doi:10.1111/bjh.12390]

Caballero-Velazquez, T; Lopez-Corral, L; Encinas, C; Castilla-Llorente, C; Martino, R; Rosinol, L; Sampol, A; Caballero, D; Serrano, D; Heras, I; San Miguel, J; Perez-Simon, JA.

Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients

BRITISH JOURNAL OF HAEMATOLOGY. 2013; 162(4): 474-482 Nº de citas: 35 [doi:10.1111/bjh.12410]

Perez, AP; Lopez, FC; Simoneau, DS; Nofuentes, PB; Fernandez, RS.

Abdominal necrotic plaque in an immunocompromised patient

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2013; 69(2): [doi:10.1016/j.jaad.2012.11.041]

Rodriguez-Macias, G; Martinez-Laperche, C; Gayoso, J; Noriega, V; Serrano, D; Balsalobre, P; Munoz-Martinez, C; Diez-Martin, JL; Buno, I.

Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia

HUMAN PATHOLOGY. 2013; 44(8): 1696-1699 Nº de citas: 11 [doi:10.1016/j.humpath.2013.01.001]

Odqvist, L; Sanchez-Beato, M; Montes-Moreno, S; Martin-Sanchez, E; Pajares, R; Sanchez-Verde, L; Ortiz-Romero, PL; Rodriguez, J; Rodriguez-Pinilla, SM; Iniesta-Martinez, F; Solera-Arroyo, JC; Ramos-Asensio, R; Flores, T; Palanca, JM; Bragado, FG; Franjo, PD; Piris, MA.

NIK Controls Classical and Alternative NF-kappa B Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells

CLINICAL CANCER RESEARCH. 2013; 19(9): 2319-2330 Nº de citas: 52 [doi:10.1158/1078-0432.CCR-12-3151]